Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

China Acute Myocardial Infarction Registry (CAMIRegistry)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01874691
Recruitment Status : Completed
First Posted : June 11, 2013
Last Update Posted : January 25, 2018
Sponsor:
Information provided by (Responsible Party):
Yuejin Yang, Chinese Academy of Medical Sciences, Fuwai Hospital

Brief Summary:
This study is to build a Chinese national registry and surveillance system for acute myocardial infarction(AMI) to obtain real-world information about current status of characteristics, risk factors, diagnosis, treatment and outcomes of Chinese AMI patients; And to propose scientific precaution strategies aimed to prevent effectively from the incidence of AMI; And to optimize the management and outcomes of AMI patients through implementation of guideline recommendations in clinical practice, and analysis and development of effective treatment strategies; And to create cost-effective assessment system.

Condition or disease
Acute Myocardial Infarction

Detailed Description:
The aim of the study is to establish the national platform for surveillance, clinical research and translational medicine in China, designed to facilitate efforts to improve the quality of AMI patient care and thus decrease morbidity and mortality associated with AMI.

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 20000 participants
Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration: 2 Years
Official Title: China Acute Myocardial Infarction Registry
Actual Study Start Date : January 2013
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016

Resource links provided by the National Library of Medicine


Group/Cohort
acute myocardial infarction
acute myocardial infarction including ST-elevation and non ST-elevation myocardial infarction



Primary Outcome Measures :
  1. In-hospital mortality of the patients with acute myocardial infarction in different-level hospitals across China [ Time Frame: the duration of hospital stay, an expected average of 2 weeks ]
    Different-level hospitals include Provincial-level, city-level, County-level hospitals from all over China.


Secondary Outcome Measures :
  1. The rate of the application of thrombolysis and primary percutaneous coronary intervention for Chinese patients with acute myocardial infarction in different-level hospitals [ Time Frame: 24 hours ]
    In different-level hospitals, How many patients with acute myocardial infarction receive thrombolysis and/or primary percutaneous coronary intervention within 24 hours from the onset,respectively?

  2. provoking factors of Chinese patients with AMI across different areas and different population in China [ Time Frame: 24 hours ]
    The different factors that can provoke the onset of acute myocardial infarction, for example, excess exercise, overload work, heavy smoking, heavy drinking of alcohol and so on.


Other Outcome Measures:
  1. the in-hospital cost of Chinese patients with acute myocardial infarction [ Time Frame: the duration of hospital stay, an expected average of 2 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Eligible patients admitted within 7 days of acute ischemic symptoms and diagnosed acute ST-elevation or non ST-elevation myocardial infarction.
Criteria

Inclusion Criteria:

  • Eligible patients must be admitted within 7 days of acute ischemic symptoms and diagnosed acute ST-elevation or non ST-elevation myocardial infarction. Diagnosis criteria must meet Universal Definition for AMI (2012). All participating hospitals are required to enroll consecutive patients with AMI.

Exclusion Criteria:

  • Myocardial infarction related to percutaneous coronary intervention and coronary artery bypass grafting.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01874691


Locations
Layout table for location information
China, Beijing
Fuwai Hospital
Beijing, Beijing, China, 100037
Sponsors and Collaborators
Chinese Academy of Medical Sciences, Fuwai Hospital
Investigators
Layout table for investigator information
Study Chair: Yuejin Yang, MD. Fuwai Hospital, Chinse Academy of Medical Sciences

Additional Information:

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Yuejin Yang, Doctor, Chinese Academy of Medical Sciences, Fuwai Hospital
ClinicalTrials.gov Identifier: NCT01874691    
Other Study ID Numbers: 2011BAI11B02-A
2011BAI11B02 ( Other Grant/Funding Number: Chinese Ministry of Science and Technology )
First Posted: June 11, 2013    Key Record Dates
Last Update Posted: January 25, 2018
Last Verified: January 2018
Keywords provided by Yuejin Yang, Chinese Academy of Medical Sciences, Fuwai Hospital:
acute myocardial infarction
China
Registry
Additional relevant MeSH terms:
Layout table for MeSH terms
Myocardial Infarction
Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases